No Data
No Data
Express News | Beyondspring Presents Updated Efficacy Results From a Phase 2 Iit Study of Triple IO Combo of Pembrolizumab Plus Plinabulin/Docetaxel in Metastatic Nsclc After Progressing on Prior Immune Checkpoint Inhibitors at the 39TH SITC Annual Meeting
BeyondSpring Presents Updated Efficacy Results From a Phase 2 IIT Study of Triple IO Combo of Pembrolizumab Plus Plinabulin/Docetaxel in Metastatic NSCLC After Progressing on Prior Immune Checkpoint Inhibitors at the 39th SITC Annual Meeting
Express News | U.S.-Listed Shares of Chinese Firms Drop Premarket on Worries Over Growing U.S.-China Trade Tensions Under Trump Presidency
Goldman Sachs Raises China Economic Growth Forecasts
China's Stocks Lose Steam as Enthusiasm for Major Stimulus Wanes. What's Next?
Today's Pre-Market Movers and Top Ratings | LI, BABA, NKE and More
No Data
No Data